HPC
TEVA icon

HM Payson & Co’s Teva Pharmaceuticals TEVA Stock Holding History

HM Payson & Co’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50
Closed -$1K – 1174
2021
Q1 		$1K Buy
+50
New +$573 ﹤0.01% 1107
2019
Q4 		– Sell
-750
Closed -$5K – 970
2019
Q3 		$5K Hold
750
– – ﹤0.01% 878
2019
Q2 		$7K Buy
+750
New +$9.04K ﹤0.01% 857
2017
Q3 		– Sell
-33,764
Closed -$1.12M – 345
2017
Q2 		$1.12M Sell
33,764
-13,586
-29% -$421K 0.05% 178
2017
Q1 		$1.52M Sell
47,350
-5,049
-10% -$172K 0.07% 159
2016
Q4 		$1.9M Sell
52,399
-14,809
-22% -$591K 0.09% 140
2016
Q3 		$3.09M Sell
67,208
-1,656
-2% -$86.4K 0.15% 113
2016
Q2 		$3.46M Sell
68,864
-3,991
-5% -$212K 0.17% 100
2016
Q1 		$3.9M Sell
72,855
-9,582
-12% -$562K 0.2% 97
2015
Q4 		$5.41M Buy
82,437
+1,488
+2% +$92K 0.28% 84
2015
Q3 		$4.57M Sell
80,949
-9,475
-10% -$614K 0.25% 92
2015
Q2 		$5.34M Sell
90,424
-17,661
-16% -$1.09M 0.27% 88
2015
Q1 		$6.73M Sell
108,085
-97,239
-47% -$5.65M 0.34% 77
2014
Q4 		$11.8M Sell
205,324
-9,988
-5% -$556K 0.58% 52
2014
Q3 		$11.6M Sell
215,312
-4,387
-2% -$232K 0.59% 50
2014
Q2 		$11.5M Sell
219,699
-105,269
-32% -$5.38M 0.59% 52
2014
Q1 		$17.2M Sell
324,968
-65,547
-17% -$3.03M 0.91% 38
2013
Q4 		$15.7M Buy
390,515
+9,456
+2% +$372K 0.84% 37
2013
Q3 		$14.4M Buy
381,059
+23,980
+7% +$935K 0.83% 40
2013
Q2 		$14M Buy
+357,079
New +$13.9M 0.84% 40

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

HM Payson & Co's TEVA Position: Q2 2021 in Review

HM Payson & Co sold out of Teva Pharmaceuticals (TEVA) in Q2 2021, closing a stake of 50 shares — an estimated $1K sold.

HM Payson & Co first reported a position in TEVA in Q2 2013 and held it in 20 quarters. The position peaked at $17.2M in Q1 2014. 440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

  • HM Payson & Co reported no remaining Teva Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • HM Payson & Co sold 50 Teva Pharmaceuticals shares in Q2 2021, an estimated $1K.
  • HM Payson & Co first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 20 quarters.
  • HM Payson & Co's Teva Pharmaceuticals position peaked at $17.2M in Q1 2014.
  • 440 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2021.

Based on HM Payson & Co's 13F filing for Q2 2021, filed 17 Aug 2021.